Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women

PHASE3CompletedINTERVENTIONAL
Enrollment

422

Participants

Timeline

Start Date

February 8, 2018

Primary Completion Date

September 26, 2018

Study Completion Date

September 26, 2018

Conditions
Edematous Fibrosclerotic Panniculopathy (Cellulite)
Interventions
BIOLOGICAL

EN3835

Collagenase clostridium histolyticum

BIOLOGICAL

Placebo

Placebo

Trial Locations (25)

10016

Endo Clinical Trial Site #17, New York

11733

Endo Clinical Trial Site #16, East Setauket

24501

Endo Clinical Trial Site #25, Lynchburg

33137

Endo Clinical Trial Site #9, Miami

33146

Endo Clinical Trial Site #8, Coral Gables

37215

Endo Clinical Trial Site #19, Nashville

45212

Endo Clinical Trial Site #18, Cincinnati

46032

Endo Clinical Trial Site #11, Carmel

48088

Endo Clinical Trial Site #14, Warren

70006

Endo Clinical Trial Site #12, Metairie

70124

Endo Clinical Trial Site #13, New Orleans

72116

Endo Clinical Trial Site #2, North Little Rock

77494

Endo Clinical Trial Site #22, Houston

77701

Endo Clinical Trial Site #21, Beaumont

78229

Endo Clinical Trial Site #23, San Antonio

78759

Endo Clinical Trial Site #20, Austin

80111

Endo Clinical Trial Site #7, Greenwood Village

83651

Endo Clinical Trial Site #10, Nampa

84101

Endo Clinical Trial Site #24, Salt Lake City

85308

Endo Clinical Trial Site #1, Glendale

90210

Endo Clinical Trial Site #3, Beverly Hills

92121

Endo Clinical Trial Site #6, San Diego

92562

Endo Clinical Trial Site #4, Murrieta

92663

Endo Clinical Trial Site #5, Newport Beach

07042

Endo Clinical Trial Site #15, Montclair

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY